HCW Biologics (HCWB)
3.49
+0.11 (3.25%)
Upcoming Events
Latest Headlines
Form POS AM HCW Biologics Inc.
July 16, 2026 6:13 AM - SEC Filing
Form 8-K HCW Biologics Inc. For: Jul 01
July 1, 2026 8:30 AM - SEC Filing
Form 8-K HCW Biologics Inc. For: Jun 29
June 30, 2026 8:30 AM - SEC Filing
HCW Biologics regains Nasdaq bid price compliance, plans reverse split
June 30, 2026 8:26 AM - StreetInsider
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
June 30, 2026 8:25 AM - StreetInsider
Form 8-K HCW Biologics Inc. For: Jun 24
June 26, 2026 9:00 AM - SEC Filing
HCW Biologics sets 1-for-6 reverse stock split for June 30
June 26, 2026 8:55 AM - StreetInsider
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
June 26, 2026 8:55 AM - StreetInsider
Form EFFECT HCW Biologics Inc.
June 22, 2026 6:03 AM - SEC Filing
Form S-1/A HCW Biologics Inc.
June 18, 2026 1:05 PM - SEC Filing
Form 8-K HCW Biologics Inc. For: Jun 16
June 16, 2026 7:16 AM - SEC Filing
HCW Biologics reports positive Phase 1 data for alopecia drug HCW9302
June 16, 2026 7:00 AM - StreetInsider
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
June 16, 2026 7:00 AM - StreetInsider
Form 8-K HCW Biologics Inc. For: Jun 15
June 15, 2026 4:30 PM - SEC Filing
Form D HCW Biologics Inc.
June 8, 2026 4:12 PM - SEC Filing
HCW Biologics (HCWB) files for 5.69M share offering by selling stockholders
June 8, 2026 10:13 AM - StreetInsider
Form S-1 HCW Biologics Inc.
June 8, 2026 10:10 AM - SEC Filing
Form 8-K HCW Biologics Inc. For: May 29
June 1, 2026 7:30 AM - SEC Filing
HCW Biologics Inc. (HCWB) PT Raised to $5 at Maxim Group
May 28, 2026 2:34 PM - StreetInsider
Form 4 HCW Biologics Inc. For: May 22 Filed by: Wong Hing C
May 27, 2026 7:27 PM - SEC Filing
Form 4 HCW Biologics Inc. For: May 22 Filed by: GARRETT SCOTT T
May 27, 2026 7:25 PM - SEC Filing
Form 4 HCW Biologics Inc. For: May 22 Filed by: Byam Rebecca
May 27, 2026 7:24 PM - SEC Filing
Form 8-K HCW Biologics Inc. For: May 21
May 27, 2026 8:00 AM - SEC Filing
HCW Biologics regains rights to CAR-T therapy reagents from Wugen
May 27, 2026 7:45 AM - StreetInsider
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
May 27, 2026 7:45 AM - StreetInsider
HCW Biologics raises $4 million in private placement with E.F. Hutton
May 22, 2026 4:03 PM - StreetInsider
E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement
May 22, 2026 4:03 PM - StreetInsider
Form 8-K HCW Biologics Inc. For: May 21
May 21, 2026 4:59 PM - SEC Filing
HCW Biologics prices $4 million private placement offering
May 21, 2026 9:53 AM - StreetInsider
HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules
May 21, 2026 9:53 AM - Globe NewsWire
Form POS AM HCW Biologics Inc.
May 18, 2026 8:27 AM - SEC Filing
Form SCHEDULE 13G/A HCW Biologics Inc. Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:21 AM - SEC Filing
Biologics Market Momentum Accelerates Across Healthcare, AI, And Global Medical Tourism
May 15, 2026 10:15 AM - StreetInsider
HCW Biologics (HCWB) Tops Q1 EPS by 37c
May 14, 2026 5:51 PM - StreetInsider
Form 10-Q HCW Biologics Inc. For: Mar 31
May 14, 2026 4:33 PM - SEC Filing
Form 8-K HCW Biologics Inc. For: May 14
May 14, 2026 4:31 PM - SEC Filing
HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results
May 14, 2026 4:25 PM - StreetInsider
HCW Biologics discovers drug candidate prevents lung disease in infants
May 14, 2026 7:31 AM - StreetInsider
HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies
May 14, 2026 7:30 AM - StreetInsider
Form POS AM HCW Biologics Inc.
May 13, 2026 4:37 PM - SEC Filing
Form 8-K HCW Biologics Inc. For: Apr 30
April 30, 2026 4:32 PM - SEC Filing
HCW Biologics adjourns special meeting due to lack of quorum
April 30, 2026 4:20 PM - StreetInsider
HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
April 30, 2026 4:20 PM - StreetInsider
Form EFFECT HCW Biologics Inc.
April 30, 2026 6:16 AM - SEC Filing
Form 8-K HCW Biologics Inc. For: Apr 29
April 30, 2026 6:13 AM - SEC Filing
Form DEF 14A HCW Biologics Inc. For: Apr 28
April 29, 2026 11:25 AM - SEC Filing
Form ARS HCW Biologics Inc. For: Dec 31
April 28, 2026 5:29 PM - SEC Filing
HCW Biologics reveals mechanism for cancer T-cell engager HCW11-018b
April 27, 2026 7:30 AM - StreetInsider
HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors
April 27, 2026 7:30 AM - Globe NewsWire
Form S-1/A HCW Biologics Inc.
April 24, 2026 5:30 PM - SEC Filing
Form S-1 HCW Biologics Inc.
April 23, 2026 7:16 PM - SEC Filing
Full Article List
